Список литературы

1. Robinson RW, Demirel M, LeBeau RJ. Natural history of cerebralthrombosis: 9 - 19 yearsfollow-up. J Chronic. Dis 1968; 21: 221

2. Bogousslavsky J, Van MG, Regli F. The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with firststroke. Stroke. 1988; 19: 1083 - 1092.

3. Бокерия Л.А., Гудкова Р.Г. Сердечно-сосудистая хирургия. 2010; Болезни и врожденные аномалии системы кровообращения. М.: НЦССХ им. А.Н. Бакулева РАМН. 2011; 192.

4. Клиническая ангиология. Руководство для врачей/Под. ред. А.В. Покровского. М.: Медицина, 2004; 1: 808.

5. Blakeley DD, Oddone EZ, Hasselblad V, etal. Noninvasive carotid artery testing: a meta-analytic review. Ann Intern Med. 1995; 122: 360 - 7.

6. AbuRahma AF, Robinson PA, Strickler DL, et al. Proposed new duplex classification for threshold stenoses used in various symptomatic and asymptomatic carotid endarterectomy trials. Ann Vasc Surg. 1998; 12: 349 - 58.

7. Carotid Artery Stenosis. Current and Emerging Treatments/ Ed. Chatuverdi S., Rothwell P. Boca Raton: Taylor & Francis Group, LLC. 2005; 359.

8. Leonardi M, Cenni P, Simonetti L, et al. Retrospective study of complications arising during cerebral and spinal diagnostic angiography from 1998 to 2003. IntervNeuroradiol. 2005; 11: 213 - 21.

9. Fayed AM, White CJ, Ramee SR, et al. Carotid and cerebral angiography performed by cardiologists: cerebrovascular complications. Catheter CardiovascInterv. 2002; 55: 277 - 80.

10. Engelter S, Lyrer P. Antiplatelet therapy for preventing stroke andother vascular events after carotid endarterectomy. Cochrane Database of Systematic Reviews 2003, Issue 3. Art. No.: CD001458. DOI: 10. 1002/14651858. CD001458.

11. Diener HC, Cunha L, Forbes C, et al. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996; 143: 1 - 13.

12. Bhatt DL, Fox KA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006; 354: 1706 - 17.

13. Palareti G, Legnani C. Warfarin with draw al. Pharmacokinetic-pharmacodynamic considerations. ClinPharmacokinet. 1996; 30: 300 - 313.

14. Payne DA, Jones CI, Hayes PD, et al. Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy. Circulation. 2004; 109: 1476 - 1481.

15. Durazzo AE, Machado FS, Ikeoka DT, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: arandomized trial. J Vasc Surg. 2004; 39: 967 - 976.

16. Iso H, Jacobs DR, Wentworth D Jr., et al. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med. 1989; 320: 904 - 10.

17. Briel M, Studer M, Glass TR, et al. Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med. 2004; 117: 596 - 606.

18. Blankenhorn DH, Selzer RH, Crawford DW, et al. Beneficial effects of colestipol-niacin therapy on the common carotid artery: two - and four-year reduction of intima-media thickness measured by ultrasound. Circulation. 1993; 88: 20 - 8.

19. Taylor AJ, Sullenberger LE, Lee HJ, et al. Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended release niacin on atherosclerosis progression in secondary prevention patients treated with statins. Circulation. 2004; 110: 3512 - 7.

20. Moore WS, Barnett HJ, Beebe HG, et al. Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the ad hoc committee. Stroke. 1995; 26: 188 - 201

21. AbuRahma A, Hannay S, Khan JH, et al. Prospective randomised study of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: perioperative (30-day) results. J VascSurg. 2002; 35: 125 - 130.

22. Gonzalez-Fajardo JA, Perez JL, Mateo AM. Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. Journal of Cardiovasc Surg. 1994; 35: 523 - 528.

23. Katz SG, Kohl RD. Does the choice of material influence early morbidity in patients undergoing carotid patch angioplasty? Surgery. 1996; 119: 297 - 301.

24. Hayes PD, Allroggen H, Steel S, et al. Randomized trial of vein versus Dacron patching DURING carotid endarterectomy: influence of patch type on postoperative embolization. J Vasc Surg. 2001; 33: 994 - 1000.

25. Kinney EV, Seabrooke G, Kinney LY, et al. The importance of intra-operative detection of residual flow abnormalities after carotid endarterectomy. J Vasc Surg. 1993; 17: 912 - 922.

26. Veith FJ, Amor M, Ohki T, et al. Current status of carotid bifurcation angioplasty and stenting based on a consensus of opinion leaders. J Vasc Surg. 2001; 33(2Suppl): S111 - 116.

27. Brooks WH, McClure RR, Jones MR, et al. Carotid angioplasty and stenting vesus carotid endarterectomy: randomised trial in a community hospital. J Am CollCardiol. 2001; 38: 1589 - 1595.

28. De Donato G, Setacci C, Deloose K, et al. Long-term results of carotid artery stenting. J Vasc Surg. 2008: in press.

29. Gray WA, Hopkins LN, Yadav S, et al. Protected carotid stenting in high-surgical-risk patients: the ARCHeR results. J Vasc Surg. 2006; 44: 258 - 68.

30. Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004; 351: 1493 - 501.

31. Gray WA, Yadav JS, Verta P, et al. The CAPTURE registry: results of carotid stenting with embolic protection in the post approval setting. CatheterCardiovascInterv. 2007; 69: 341 - 8.